Alzheimer Patients and the Snoezelen Program

Sponsor
Queen's University (Other)
Overall Status
Completed
CT.gov ID
NCT00548951
Collaborator
(none)
18
1
3
15
1.2

Study Details

Study Description

Brief Summary

To determine the connection between Social Withdrawal and Sensory Deprivation in elderly clients with Alzheimer's Type Dementia (i.e. how providing sensory stimulation might reduce social withdrawal).

Condition or Disease Intervention/Treatment Phase
  • Other: Snoezelen Room
  • Other: Snoezelen Room
  • Other: Control
Phase 1

Detailed Description

The Snoezelen concept or program was originally thought up in Holland and comes from two Dutch words meaning to "sniff and doze". It was first introduced in the Netherlands in the 1970's. The first room was introduced in Snoezelen examines how a group of people react to an area that is private, relaxed and one that they trust. This program will bring out one's sense of taste, touch, smell, sight and hearing just by being in a specially designed room. Trust and relaxation will be looked at by those people with developmental disabilities (those that learn at a slower rate). Snoezelen originated with the belief that everyone needs nerve pulses (senses).

Inside a Snoezelen room you will find, dimmed lights, a relaxed atmosphere and pleasant surroundings, soothing sounds, intriguing aromas, tasty puddings, candies, interesting light effects (fiber optic light spray), comfortable seating, opportunities for interaction and engagement, sense of control over environment, tactile objects (awareness box), bubble tube, solar projector wheel, water fountain, massage pillow, massage tube, tranquility and solitude. The Snoezelen room is an environment in which the primary senses (see, hear, taste, touch) are stimulated all to create an environment that is both relaxing and stimulating. The benefits of Snoezelen change per person but may include some of the following:

  • Increased resident and caregiver communication

  • Increased awareness and understanding of the environment

The Snoezelen idea: client-controlled, safe comfortable atmosphere and freedom from pressure.

Sensory Deprivation (loss) The average person touches 300 different surfaces every 30 minutes. The average person with a profound disability will likely touch 1-5 surfaces in the same time frame.

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Connection Between Sensory Deprivation and Social Withdrawal in Clients of a Long Term Care Facility Living With Alzheimer's Disease and the Effects of a Snoezelen Program.
Study Start Date :
Sep 1, 2005
Actual Primary Completion Date :
Dec 1, 2006
Actual Study Completion Date :
Dec 1, 2006

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Subject receives Snoezelen sessions once per week.

Other: Snoezelen Room
Session in a Snoezelen room once per week for 12 weeks

Active Comparator: 2

Subject receives Snoezelen sessions three times per week.

Other: Snoezelen Room
Session in a Snoezelen room three times per week for 12 weeks

Other: 3

Subject receives no sessions per week.

Other: Control
Receive no sessions in a Snoezelen Room.

Outcome Measures

Primary Outcome Measures

  1. To evaluate improvement of the residents who are given Snoezelen sessions. [12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Residents living at Rideaucrest Home (Long Term Care Facility in Kingston, Ontario);

  • Residents having a Mini Mental State Exam with a score of 15 to 27 reflecting mild to moderate dementia;

  • Male or female over 65 years of age;

  • Resident who are able to leave the terrace;

  • Resident who are not actively participating in Life Enrichment Programs;

  • Able to provide informed written and signed consent by resident or substitute decision maker.

Exclusion Criteria:
  • Suffering from severe life threatening illness with a reasonable expectation of death within the next six month;

  • Severe mental disorder in the opinion of the investigator (i.e. bipolar, schizophrenia);

  • No recent change in medication(s) during the past four weeks prior to the project;

  • Other non-Alzheimer-Type Dementia;

  • Residents who suffer from Epilepsy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rideaucrest Home Kingston Ontario Canada K7K 3H6

Sponsors and Collaborators

  • Queen's University

Investigators

  • Principal Investigator: Roumen V. Milev, MD, Queen's University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Roumen Milev, Principal Investigator, Queen's University
ClinicalTrials.gov Identifier:
NCT00548951
Other Study ID Numbers:
  • PSIY-205-05
First Posted:
Oct 24, 2007
Last Update Posted:
Dec 16, 2015
Last Verified:
Dec 1, 2015
Keywords provided by Dr. Roumen Milev, Principal Investigator, Queen's University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 16, 2015